Depression, Bipolar & Grief Counselling Blog

VNS treatment for bipolar depression

Medical company LivaNova are pumped about their latest results for treatment-resistant bipolar disorder sufferers.

They recently announced the publication of a new study that showed adding vagus nerve stimulation (VNS) therapy to treatment-as-usual significantly improves outcomes in patients with treatment-resistant bipolar depression (TRBD).

Patients who received adjunctive VNS therapy responded more quickly and experienced more durable antidepressant effects than those just receiving treatment-as-usual (TAU). The study concluded that adjunctive VNS therapy is an efficacious antidepressant treatment for patients with TRBD.

“LivaNova is dedicated to helping patients who suffer from treatment-resistant bipolar depression. We are heartened to see that the results of this five-year study show that patients receiving adjunctive VNS therapy were more likely to respond and experienced a faster and more durable response than patients treated with TAU alone. Moreover, the study reconfirmed that adjunctive VNS therapy significantly lowers suicidality, a very important and key factor when considering the overall positive impact on the lives of patients and their loved ones.”

Bryan Olin, SVP for clinical, quality and regulatory affairs, LivaNova



Share on facebook
Share on twitter
Share on linkedin

More Posts

SFBT and the small things

One of the fascinating aspects of a growing therapeutic model is what happens on the outside edges. BRIEF is a very successful Solution-Focused therapy practice